0001213900-24-030811.txt : 20240405
0001213900-24-030811.hdr.sgml : 20240405
20240405160521
ACCESSION NUMBER: 0001213900-24-030811
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240403
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazur Leonard L
CENTRAL INDEX KEY: 0001463414
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38174
FILM NUMBER: 24826462
MAIL ADDRESS:
STREET 1: C/O CITIUS PHARMACEUTICALS, INC.
STREET 2: 11 COMMERCE DRIVE, 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001506251
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273425913
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: (908) 967-6676
MAIL ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
FORMER COMPANY:
FORMER CONFORMED NAME: Trail One, Inc.
DATE OF NAME CHANGE: 20110314
FORMER COMPANY:
FORMER CONFORMED NAME: TrailOne, Inc.
DATE OF NAME CHANGE: 20101119
4
1
ownership.xml
X0508
4
2024-04-03
0
0001506251
Citius Pharmaceuticals, Inc.
CTXR
0001463414
Mazur Leonard L
C/O CITIUS PHARMACEUTICALS, INC.
11 COMMERCE DRIVE, 1ST FLOOR
CRANFORD
NJ
07016
1
1
1
0
Chief Executive Officer
0
Common Stock
10255343
D
Warrant to Purchase Common Stock
1.42
2024-04-03
4
D
0
1165048
D
2024-04-05
Common Stock
1165048
0
D
Warrant to Purchase Common Stock
1.42
2024-04-03
4
A
0
1165048
A
2025-04-05
Common Stock
1165048
1165048
D
Stock Option (Right to Purchase Common Stock)
0.70
2033-10-10
Common Stock
550000
550000
D
Stock Option (Right to Purchase Common Stock)
1.25
2032-10-04
Common Stock
550000
550000
D
Stock Option (Right to Purchase Common Stock)
2.04
2031-10-11
Common Stock
650000
650000
D
Stock Option (Right to Purchase Common Stock)
2.00
2031-07-22
Common Stock
300000
300000
D
Stock Option (Right to Purchase Common Stock)
1.01
2030-10-06
Common Stock
200000
200000
D
Stock Option (Right to Purchase Common Stock)
0.67
2029-10-08
Common Stock
175000
175000
D
Warrant to Purchase Common Stock
0.77
2024-09-27
Common Stock
2234700
2234700
D
Stock Option (Right to Purchase Common Stock)
1.62
2028-09-04
Common Stock
150000
150000
D
Warrant to Purchase Common Stock
1.15
2024-08-14
Common Stock
3137255
3137255
D
Stock Option (Right to Purchase Common Stock)
6.75
2024-09-12
Common Stock
220000
220000
D
Stock Option (Right to Purchase Common Stock)
3.45
2027-09-13
Common Stock
40000
40000
D
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.
The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date
The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date
The options vested in full on October 6, 2023.
The options vested in full on October 8, 2022.
The warrant is fully vested and exercisable immediately.
The options vested in full on September 4, 2021
The options vested in full on September 12, 2017.
The options vested in full on September 13, 2020.
/s/ Alexander M. Donaldson, by power of attorney
2024-04-05